XML 39 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments And Hedging Activities
12 Months Ended
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments And Hedging Activities
Derivative Instruments and Hedging Activities
 
In June 2015, we entered into interest rate swap contracts to fix the interest rate on $187.5 million of our Nordea Q5000 Loan borrowings (Note 6). These swap contracts, which are settled monthly, began in June 2015 and extend through April 2020. Our interest rate swap contracts qualify for cash flow hedge accounting treatment. The amount of ineffectiveness associated with our interest rate swap contracts was immaterial for all periods presented.
 
In February 2013, we entered into foreign currency exchange contracts to hedge our foreign currency exposure associated with the Grand Canyon II and Grand Canyon III charter payments denominated in Norwegian kroner through July 2019 and February 2020, respectively. Unrealized losses associated with the effective portion of our foreign currency exchange contracts that qualify for hedge accounting treatment are reflected in “Accumulated other comprehensive loss” in the shareholders’ equity section of the accompanying consolidated balance sheets (net of tax). Changes in unrealized losses associated with the foreign currency exchange contracts that are not designated as cash flow hedges are reflected in “Other income (expense), net” in the accompanying consolidated statements of operations. Hedge ineffectiveness also is reflected in “Other income (expense), net” in the accompanying consolidated statements of operations. The amount of ineffectiveness associated with our foreign currency exchange contracts was immaterial for all periods presented.
 
The following table presents the balance sheet location and fair value of our derivative instruments that were designated as hedging instruments (in thousands): 
 
December 31,
 
2018
 
2017
 
Balance Sheet
Location
 
Fair
Value
 
Balance Sheet
Location
 
Fair
Value
Asset Derivative Instruments:
 
 
 
 
 
 
 
Interest rate swaps
Other current assets
 
$
863

 
Other current assets
 
$
311

Interest rate swaps
Other assets, net
 
201

 
Other assets, net
 
655

 
 
 
$
1,064

 
 
 
$
966

 
 
 
 
 
 
 
 
Liability Derivative Instruments:
 
 
 
 
 
 
Foreign exchange contracts
Accrued liabilities
 
$
5,857

 
Accrued liabilities
 
$
7,492

Foreign exchange contracts
Other non-current liabilities
 
354

 
Other non-current liabilities
 
4,975

 
 
 
$
6,211

 
 
 
$
12,467


 
The following table presents the balance sheet location and fair value of our derivative instruments that were not designated as hedging instruments (in thousands): 
 
December 31,
 
2018
 
2017
 
Balance Sheet
Location
 
Fair
Value
 
Balance Sheet
Location
 
Fair
Value
Liability Derivative Instruments:
 
 
 
 
 
 
Foreign exchange contracts
Accrued liabilities
 
$
3,454

 
Accrued liabilities
 
$
3,133

Foreign exchange contracts
Other non-current liabilities
 
530

 
Other non-current liabilities
 
3,175

 
 
 
$
3,984

 
 
 
$
6,308


 
The following tables present the impact that derivative instruments designated as hedging instruments had on our accumulated OCI (net of tax) and our consolidated statements of operations (in thousands). We estimate that as of December 31, 2018, $4.0 million of net losses in accumulated OCI associated with our derivative instruments is expected to be reclassified into earnings within the next 12 months.
 
Unrealized Gain (Loss) Recognized in OCI
 
Year Ended December 31,
 
2018
 
2017
 
2016
 
 
 
 
 
 
Foreign exchange contracts
$
(1,453
)
 
$
2,672

 
$
3,630

Interest rate swaps
606

 
651

 
(1,264
)
 
$
(847
)
 
$
3,323

 
$
2,366


 
 
Location of Gain (Loss)
Reclassified from
Accumulated OCI
into Earnings
 
Gain (Loss) Reclassified from
Accumulated OCI into Earnings
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
 
 
 
 
 
 
 
 
Foreign exchange contracts
Cost of sales
 
$
(7,709
)
 
$
(12,300
)
 
$
(10,827
)
Interest rate swaps
Net interest expense
 
508

 
(615
)
 
(2,024
)
 
 
 
$
(7,201
)
 
$
(12,915
)
 
$
(12,851
)

 
The following table presents the impact that derivative instruments not designated as hedging instruments had on our consolidated statements of operations (in thousands): 
 
Location of Gain (Loss)
Recognized in Earnings
 
Gain (Loss) Recognized in Earnings
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
 
 
 
 
 
 
 
 
Foreign exchange contracts
Other income (expense), net
 
$
(901
)
 
$
818

 
$
1,198

 
 
 
$
(901
)
 
$
818

 
$
1,198